Evidence map›Paper›PMID 18200031›Full record

ArticleGenes and immunity2008

SNPs upstream of the minimal promoter control IL-2 expression and are candidates for the autoimmune disease-susceptibility locus Aod2/Idd3/Eae3.

R del Rio, R Noubade, M Subramanian, N Saligrama, S Diehl, M Rincon, C Teuscher

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Regulatory T cells and vasectomy.Journal of reproductive immunology · 2013
    Article
  5. Article
  6. Review
  7. Article
  8. Regulatory T cells control tolerogenic versus autoimmune response to sperm in vasectomy.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  9. Article
  10. Amino acid polymorphisms altering the glycosylation of IL-2 do not protect from type 1 diabetes in the NOD mouse.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

R del RioDepartment of Medicine, University of Vermont, Burlington, VT 5405, USA.
R Noubade
M Subramanian
N Saligrama
S Diehl
M Rincon
C Teuscher
University of Vermont · US

Funding

Synovial V delta 1 cells kill Th2 cellsP01AI045666 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI BUDD, RALPH C · 1999 to 2010
$12.5M
P53 and cell cycle checkpoint by p38 MAP kinaseR01AI051454 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI RINCON, MERCEDES · 2003 to 2019
$4.9M
Susceptibilty and Resistance Loci in Mouse EAER01NS036526 · NINDS · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI TEUSCHER, CORY · 1996 to 2008
$4.4M
AUTOIMMUNE DISEASE AND NEONATAL TOLERANCER01AI041747 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI TEUSCHER, CORY · 1997 to 2009
$1.9M
Genetics of Suscptibility to Anthrax Toxin in vivoR01AI058052 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI TEUSCHER, CORY · 2004 to 2008
$1.8M
p38 MAP kinase in early thymocyte developmentR56AI051454 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI RINCON, MERCEDES · 2008 to 2008
$376k
p53 and p38 MAP Kinase in thymocyte developmentR21AI051454 · NIAID · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI RINCON, MERCEDES R. · 2002 to 2002
$299k
NIAID NIH HHS AI041747NIAID NIH HHS AI045666NIAID NIH HHS AI051454NIAID NIH HHS AI058052NINDS NIH HHS NS036526
6 · The paper itself

Abstract

IL-2, a T-cell growth and differentiation factor, plays an important role in immune homeostasis. Previously, we identified IL2 as a candidate for Aod2, a quantitative trait locus (QTL) controlling susceptibility to autoimmune ovarian dysgenesis (AOD) induced by day 3 neonatal thymectomy. Here, we report the identification of single-nucleotide polymorphisms (SNPs) in a region upstream of the minimal IL2 promoter (-2.8 kb to -300 bp), which distinguish AOD-susceptible A/J and AOD-resistant C57BL/6J (B6/J) mice. Six of the SNPs (-1010 C --> T, -962 C --> T, -926/-925 Delta Delta --> AC, -921 T --> C, -914 T --> C and -674 G --> A) contribute to the enhanced transcriptional activity of the extended B6/J promoter relative to A/J. Importantly, the -1010 SNP resides within a canonical AP-1-binding motif with the C --> T transition at this site abrogating AP-1 binding. Moreover, these SNPs segregate with differential production of IL-2 by CD4(+) T cells as well as susceptibility alleles at Idd3 and Eae3, QTL controlling insulin-dependent diabetes mellitus and experimental allergic encephalomyelitis. These are the first SNPs identified within the extended murine IL2 promoter that control differential IL-2 transcription in CD4(+) T cells, and, as such, they are not only candidates for Aod2, but are also candidates for a shared autoimmune disease-susceptibility locus underlying Idd3 and Eae3.

Indexed as

AnimalsAutoimmune DiseasesCD4-Positive T-LymphocytesDiabetes Mellitus, Type 1Encephalomyelitis, Autoimmune, ExperimentalFemaleGene Expression RegulationGenetic MarkersGenetic Predisposition to DiseaseInterleukin-2MiceMice, Inbred AMice, Inbred C57BLMice, Inbred NODOvarian DiseasesPolymorphism, Single NucleotideGenetic MarkersInterleukin-2

Identifiers

PMID18200031
OpenAlexW2079865485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.